Short Interest in iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Decreases By 82.8%

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totaling 9,491 shares, a decline of 82.8% from the November 30th total of 55,051 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily volume of 25,599 shares, the days-to-cover ratio is currently 0.4 days. Based on an average daily volume of 25,599 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.2% of the company’s stock are sold short.

iShares Genomics Immunology and Healthcare ETF Trading Up 0.6%

Shares of iShares Genomics Immunology and Healthcare ETF stock traded up $0.15 on Thursday, reaching $26.94. 8,171 shares of the company were exchanged, compared to its average volume of 29,506. The company has a market capitalization of $136.05 million, a price-to-earnings ratio of 14.76 and a beta of 1.07. iShares Genomics Immunology and Healthcare ETF has a one year low of $17.26 and a one year high of $27.65. The company has a 50-day moving average of $25.97 and a 200 day moving average of $23.49.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

Hedge funds have recently made changes to their positions in the business. Portland Global Advisors LLC raised its stake in iShares Genomics Immunology and Healthcare ETF by 0.7% in the 3rd quarter. Portland Global Advisors LLC now owns 103,007 shares of the company’s stock valued at $2,432,000 after acquiring an additional 684 shares during the period. Triumph Capital Management bought a new position in iShares Genomics Immunology and Healthcare ETF in the 3rd quarter valued at about $35,000. Ameriprise Financial Inc. lifted its position in iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock worth $1,688,000 after acquiring an additional 5,540 shares during the last quarter. Finally, Flow Traders U.S. LLC bought a new stake in shares of iShares Genomics Immunology and Healthcare ETF during the second quarter worth approximately $931,000.

About iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.